Pediatrix Medical Group, Inc.
MDFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Pediatrix Medical Group, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
No 13F rows are listed for Pediatrix Medical Group, Inc.
- 8 rows left out: they repeat the same share count and value quarter after quarter, which a market value cannot do.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Pediatrix Medical Group, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2022-01-04 · MEDEL ROGER MD: Larger than 45 of the 48 other insider sales of Common Stock on file. SEC filing
- 2021-12-27 · MEDEL ROGER MD: Larger than 44 of the 48 other insider sales of Common Stock on file. SEC filing
- 2021-08-30 · ORDAN MARK S: Larger than 46 of the 48 other insider sales of Common Stock on file. SEC filing
- 2021-07-01 · MEDEL ROGER MD: Larger than all 48 other insider sales of Common Stock on file. SEC filing
- 2021-04-01 · MEDEL ROGER MD: Larger than 47 of the 48 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-13 | Weis Shirley A · Director | Common Stock | S — Open market or private sale | −36,028 | 23.75 | SEC filing |
| 2025-12-15 | ORDAN MARK S · Chief Executive Officer | Common Stock | S — Open market or private sale | −23,000 | 22.41 | SEC filing |
| 2025-11-17 | Rucker Michael A. · Director | Common Stock | S — Open market or private sale | −10,478 | 23.00 | SEC filing |
| 2025-11-06 | Linynsky Laura A · Director | Common Stock | S — Open market or private sale | −10,000 | 21.65 | SEC filing |
| 2024-11-13 | ORDAN MARK S · Director | Common Stock | S — Open market or private sale | −27,600 | 15.35 | SEC filing |
| 2024-11-08 | Moore Mary Ann E · EVP, GC, Chief Admin Off & Sec | Common Stock | S — Open market or private sale | −8,108 | 16.00 | SEC filing |
| 2024-08-30 | Swift James D · Chief Executive Officer | Common Stock | S — Open market or private sale | −11,100 | 10.79 | SEC filing |
| 2024-08-27 | Linynsky Laura A · Director | Common Stock | S — Open market or private sale | −7,000 | 11.16 | SEC filing |
Showing 8 of 16 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-22 | Haddock David · EVP, GC & Corp Sec | Common Stock | A — Grant, award, or other acquisition | +20,036 | SEC filing |
| 2026-06-22 | Haddock David · EVP, GC & Corp Sec | Performance Share Unit | A — Grant, award, or other acquisition | +51,000 | SEC filing |
| 2026-06-09 | Moore Mary Ann E · EVP, GC, Chief Admin Off & Sec | Common Stock | G — Bona fide gift | +18,407 | SEC filing |
| 2026-06-09 | Moore Mary Ann E · EVP, GC, Chief Admin Off & Sec | Common Stock | G — Bona fide gift | −18,407 | SEC filing |
| 2026-06-02 | ORDAN MARK S · Chief Executive Officer | Common Stock | A — Grant, award, or other acquisition | +97,174 | SEC filing |
| 2026-06-01 | Neeb Don Gregory · EVP, Chief Invest & Strategy | Common Stock | A — Grant, award, or other acquisition | +63,888 | SEC filing |
| 2026-06-01 | Rossi Kasandra H · EVP, CFO and Treasurer | Common Stock | A — Grant, award, or other acquisition | +31,800 | SEC filing |
| 2026-06-01 | ORDAN MARK S · Chief Executive Officer | Common Stock | A — Grant, award, or other acquisition | +127,198 | SEC filing |
Showing 8 of 37 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-02 | ORDAN MARK S · Chief Executive Officer | Common Stock | D — Disposition to the issuer | −97,174 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.